268 related articles for article (PubMed ID: 12735420)
1. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
[TBL] [Abstract][Full Text] [Related]
2. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
[TBL] [Abstract][Full Text] [Related]
3. [The value of functional tests in diagnosis of prolactinoma].
Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
[TBL] [Abstract][Full Text] [Related]
4. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
5. Establishment of reference values for endocrine tests. II: Hyperprolactinemia.
Le Moli R; Endert E; Fliers E; Mulder T; Prummel MF; Romijn JA; Wiersinga WM
Neth J Med; 1999 Aug; 55(2):71-5. PubMed ID: 10474275
[TBL] [Abstract][Full Text] [Related]
6. [Results of the GnRH-TRH and arginine-GnRH-TRH test in females with hyperprolactinemic galactorrhea].
Rudolf K; Kunkel S; Rudolf H
Zentralbl Gynakol; 1987; 109(8):501-9. PubMed ID: 3111128
[TBL] [Abstract][Full Text] [Related]
7. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
Westwood ME; Butler GE; McLellan AC; Barth JH
Clin Endocrinol (Oxf); 2000 Jun; 52(6):727-33. PubMed ID: 10848877
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of patients with hyperprolactinemia: have dynamic tests had their day?
Di Sarno A; Rota F; Auriemma R; De Martino MC; Lombardi G; Colao A
J Endocrinol Invest; 2003; 26(7 Suppl):39-47. PubMed ID: 14604065
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
11. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
12. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
13. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
[TBL] [Abstract][Full Text] [Related]
14. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinomas and functionless pituitary tumours. Immunostaining and effect of dopamine agonist therapy.
Gasser RW; Mueller-Holzner E; Skrabal F; Finkenstedt G; Mayr U; Tabarelli M; Spoendlin H; Grunert V; Twerdy K
Acta Endocrinol (Copenh); 1987 Oct; 116(2):253-9. PubMed ID: 3116800
[TBL] [Abstract][Full Text] [Related]
16. The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma.
Brismar K; Hulting AL; Werner S
J Intern Med; 1990 Nov; 228(5):435-42. PubMed ID: 2123920
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of thyrotropin releasing hormone test in 129 patients with suspected tumoral hyperprolactinemia.
Smircić-Duvnjak L; Vizner B; Korsić M; Sekso M; Berković M
Coll Antropol; 2002 Dec; 26(2):635-40. PubMed ID: 12528293
[TBL] [Abstract][Full Text] [Related]
18. [GnRH-TRH and arg-GnRH-TRH test in females with normoprolactinemic galactorrhea].
Rudolf K; Kunkel S; Rudolf H
Zentralbl Gynakol; 1987; 109(8):510-6. PubMed ID: 3111129
[TBL] [Abstract][Full Text] [Related]
19. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
20. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.
Colao A; Di Sarno A; Guerra E; Pivonello R; Cappabianca P; Caranci F; Elefante A; Cavallo LM; Briganti F; Cirillo S; Lombardi G
Clin Endocrinol (Oxf); 2007 Sep; 67(3):426-33. PubMed ID: 17573902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]